1 / 12

WHO-Health Action International project on drug price comparisons A technical project of the WHO-Public interest NGO rou

WHO-Health Action International project on drug price comparisons A technical project of the WHO-Public interest NGO round table on access to medicines. Background. Evidence from small-scale studies that retail price for some drugs is higher in low income countries than in high income settings

paulos
Download Presentation

WHO-Health Action International project on drug price comparisons A technical project of the WHO-Public interest NGO rou

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. WHO-Health Action International project on drug price comparisons A technical project of the WHO-Public interest NGO round table on access to medicines

  2. Background • Evidence from small-scale studies that retail price for some drugs is higher in low income countries than in high income settings • Practical difficulty of obtaining reliable, up-to-date information on drug prices particularly in low income countries • Methodological difficulty of making international price comparisons • Approach to improve price transparency and empower actors concerned with health and medicines policy • WHO-Public Interest NGO Roundtable an opportunity to launch such an initiative

  3. Objectives

  4. Sources of financial support • Netherlands government • Rockefeller Foundation • WHO • GTZ (cameroon pilot study)

  5. Elements covered • “Core list” of 30 important drugs • “Supplementary lists” adapted to local needs encouraged • Retail prices at health facilities in public, private and not-for-profit sectors - NGOs -(where all three exist) • Prices of branded drug, best selling generic drug, and lowest price generic drug to be collected • “Affordability” assessments for 9 conditions built into worksheet (use STGs, local prices, local minimum wage) • Links in price chain (Price components) from manufacturer to retailer to be identified

  6. Core list of drugs for price comparison

  7. Data collection • Self-contained Manual/Excel worksheet to guide surveys • Detailed guidance given on choosing a national or regional representative sample (25-50 facilities) based on largest urban area plus three other areas with randomly selected public, private and (where applicable) NGO facilities • Core list of 30 drugs, 3 sectors, 3 prices

  8. Country studies • Armenia, Kenya, South Africa, Brazil, Sri Lanka first pilots, then modification to methodology • Ongoing second round studies Cameroon, Philippines, Peru, Pakistan, India, Ghana • Cost to project per country study between $0 and $8000 • Overall project cost: < $300,000 • Project finishes end 2002

  9. Data analysis & availability • Recommended minimum analysis at country level built into Manual • HAI web site being developed as repository for data, allowing comparisons within and between countries for individual drug prices and their make-up.

  10. Project management - advisory board

  11. Project management - steering group • Margaret Ewen, HAI (co-ordinator) • Andrew Creese, WHO (co-ordinator) • Harry Van Schooten, Netherlands Government • Anthony So, Rockefeller Foundation • Carmen Perez Casas, MSF • Mogha Smith, Oxfam

More Related